Michael Gelb, Professor and Boris and Barbara L. Weinstein Endowed Chair in Chemistry, was selected as the 2018 recipient of the highly prestigious Repligen Corporation Award in the Chemistry of Biological Processes. This award was established in 1985 to “acknowledge and encourage outstanding contributions to the understanding of the chemistry of biological processes, with particular emphasis on structure, function, and mechanism.” The award is given annually by the Division of Biological Chemistry of the American Chemical Society.
Professor Gelb and his co-workers have made numerous seminal scientific contributions during his three decades of research at the University of Washington. Among these are the elucidation of the structure and mechanism of phospholipase A2, an enzyme that operates at the membrane-water interface, the discovery of protein prenylation, and the development of the first practical method to screen newborns for a family of rare genetic diseases. The latter protocol is being adopted world-wide.
This award is an extraordinary honor for lifetime scientific achievement in biological chemistry. Professor Gelb joins a list of previous recipients that includes leading figures in the history of biological chemistry such as Robert Abeles, Stephen Benkovic, Harold Scheraga, Frank Westheimer, Jeremy Knowles, Judith Klinman, William Jencks, Christopher Walsh, and JoAnne Stubbe. He will receive the award at an upcoming ACS national meeting, anticipated for the latter part of 2018.